2025-523873-41-00招募中1 期
A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 145
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Lilly Clinical Trials information desk
Scientific
Eli Lilly & Co.
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
1 期
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal FunctionKidney Failure, ChronicKidney DiseaseRenal InsufficiencyNCT07426380Eli Lilly and Company28
招募中
3 期
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinObesityNCT07392190Eli Lilly and Company900
招募中
3 期
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesOverweightObesityObesityNCT07282600Eli Lilly and Company1,035
招募中
1 期
A Single-Dose Pharmacokinetic Study of Eloralintide in Participants with Varying Degrees of Liver Impairment and Participants with Normal Liver FunctionParticipants with Mild, Moderate, or Severe Hepatic Impairment and Participants with Normal Hepatic Function2025-523847-36-00Eli Lilly & Co.12
招募中
3 期
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightObesityNCT07369011Eli Lilly and Company800